* U.S. judge orders Valeant Pharmaceuticals International Inc pershing square to make corrective disclosures in proxy solicitation tied to proposedAllergan Inc takeover - court ruling * U.S. district judge david carter says Valeant, pershing cannot solicitfurther proxies until corrective disclosures are made * Judge says disclosures must include how Valeant, pershing had agreed onFebruary 25 to be called "co-bidders" if Allergan-Valeant transaction
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.4% or $0.53/share to $133.38. In the past year, the shares have traded as low as $102.93 and as high as $153.10. On average, 2712530 shares of VRX exchange hands on a given day and today's volume is recorded at 1631946.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.68% or $1.03/share to $151.93. In the past year, the shares have traded as low as $107.74 and as high as $170.45. On average, 482856 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 258581.
Source
